Table 3 Univariate analysis of patients' survival
From: Classical Kaposi sarcoma: an ınsight into demographic characteristics and survival outcomes
Variable | P value | HR(95%) |
|---|---|---|
Age at diagnosis | ||
65 yr > 65 yr ≤ | 0.17 | 2.36(0.67–8.34) |
Sex | ||
Female Male | 0.91 | 1.06(0.34–3.31) |
Smoking | ||
Current or former smoking No smoking history | 0.07 | 2.63(0.91–7.63) |
Comorbidity | ||
None ≥ 1 | 0.17 | 2.00(0.72–5.52) |
LANA | ||
Positive Negative | 0.07 | 2.45(0.90–6.61) |
Clinical Form | ||
Solitary Plaque Macule | 0.88 0.33 | 0.85(0.10–6.75) 2.90(0.33–25.6) |
Stage | ||
I-II(Local) III(Locally advanced) IV(Metastatic) | 0.26 0.003 | 2.01(0.58–6.90) 5.75(1.77–18.6) |
Localization | ||
Lower extremity Upper extremity Lower + Upper extremity Whole body | 0.16 | 1.23(0.91–1.65) |
Symptoms | ||
None Lymphedema Ulceration Pain | 0.10 | 1.27(0.94–1.70) |
Treatment | ||
Observation Only Excision Radiotherapy(RT) Chemotherapy Chemoradiotherapy RT + Excision | 0.59 | 1.07(0.81–1.42) |